Pet Core, Inc

  • WKN: A0Q72D
  • ISIN: CA2302791017
  • Land: USA

Nachricht vom 30.09.2010 | 09:00

Pet Core, Inc: Eye Care ZX


Pet Core, Inc  / Key word(s): Miscellaneous

30.09.2010 09:00
---------------------------------------------------------------------------

Encinitas California - Jaeson Cayne
September 29, 2010 1+(760) 274 6888
jaeson@pet-core.com

Jaeson Cayne, Chairman of the Board of Pet Core International, Inc  is
pleased to announce an addition to its already extensive product line.  Pet
Core's scientists have created a new proprietary formulation called 'Eye
Care ZX'.

As dogs and cats get older one of the problems they encounter is a loss of
vision.  Cataracts in dogs and Feline Uveitis in cats are common
occurrences.  A Cataract is any opacity within a lens.  Eventually the
entire lens can become cloudy and all functional vision is lost.    Uveitis
is an inflammation of the uveal tract, which is the pigmented, vascular
part of the eye.  Uveitis usually chronic and can cause blindness and
ocular pain.  For Uveitis, veterinarians have said that oral nutritional
supplements would benefit cats.  For cataracts veterinary ophthalmologists
have stated that nutritional support of the lens can help to prevent or
lessen the severity of developing cataracts.  Nutritional supplementation
can help to enhance lens health by providing antioxidants designed
specifically for support of the canine eye.  Antioxidant supplementation
may also help reduce ocular inflammation that occurs in dogs both secondary
to cataract formation.

Eye Care ZX, which is also powered by Pet Core's Zentex Formulation, helps
your pets keep their vision for a longer period of time and can fight the
onset of Uveitis and cataracts.

Dr. Dennis Kramer, states that he is very proud of Eye Care ZX that his
team has created for Pet-Core, International, Inc.  'I think any pet owner
wants to do anything they can to make sure that their pet stays healthier
as they get older.  Eye Care ZX, along with the other Pet-Core products
help to do just that.'

Mr. Cayne has been a leader in mass merchandizing of products.  An
innovator in the Direct Marketing industry, Mr. Cayne's extensive
background in television and multi-media productions, executive management
or companies with revenues in the hundreds of millions coupled with his
extensive network of entertainment industry contacts makes him the perfect
choice to lead Pet Core International, Inc into a powerhouse in the Pet
Industry.  Mr. Cayne is responsible for almost a billion dollars in sales
and received recognition and multiple rewards as a highly respected and
seasoned player in the business community.

Pet Core has developed a line of proprietary products designed to insure
that pet owners can, with great confidence, provide their pets with both
healthy and nutritious food.  Pet-Core plans to capitalize on two factors: 
the dramatic growth in the consumer driven pet health market - especially
the demand for upscale natural and organic products and the growing
consumer awareness and concern over the toxins in pet food and the
processing of pet foods depleting the food of many of the necessary
nutrients required by pets.  Pet Core's product line added to the pet's
food will provide the pets a healthy and happy life.

   

      


30.09.2010 Dissemination of a Corporate News, transmitted by DGAP - 
a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.

DGAP's Distribution Services include Regulatory Announcements, 
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

---------------------------------------------------------------------------

Anleihe im Fokus

8,25% Maritim-Offshore-Anleihe

Die besicherte Maritim-Offshore-Anleihe (WKN A1MLY9 / ISIN DE000A1MLY97) mit einem Volumen von bis zu € 25 Mio. und einem Zinssatz von 8,25% kann ab dem 21. Mai 2012 gezeichnet werden.
Die Laufzeit der Anleihe beträgt 2,5 Jahre, der Kupon wird halbjährlich bezahlt.

Event im Fokus

13. MKK

13. MKK - Münchner Kapitalmarkt Konferenz
am 23. & 24. Mai 2012
Über 20 Gesellschaften aus dem Small- und Mid-Cap Bereich präsentieren sich
im SOFITEL Munich Bayerpost

GBC-Fokusbox

HELMA Eigenheimbau: Rekordwerte

Im abgelaufenen Geschäftsjahr legte HELMA Eigenheimbau AG bei der Umsatz– und Ergebnisdynamik deutlich zu und erreichte damit neue Rekordwerte. Auf Basis unseres DCF-Modells haben wir einen 2012er fairen Unternehmenswert von 19 € je Aktie ermittelt. Unser Rating lautet „KAUFEN“.

News im Fokus

SAP AG: SAP erweitert Cloud-Geschäft mit Akquisition von Ariba

22. Mai 2012, 20:48

Aktueller Webcast

Aktuelle Research-Studie

KINGHERO AG

Original-Research: Kinghero AG (von GBC AG): Kaufen

23. Mai 2012